Copyright Reports & Markets. All rights reserved.

Global Ophthalmic Perfluoropropane Gas (C3F8) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Pure C3F8
    • 1.3.3 Gas Mixture
  • 1.4 Market Analysis by Specification
    • 1.4.1 Overview: Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Specification: 2021 Versus 2025 Versus 2032
    • 1.4.2 30 ml/unit
    • 1.4.3 40 ml/unit
    • 1.4.4 Others
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Retinal Detachment Repair
    • 1.5.3 Macular Hole Surgery
    • 1.5.4 Others
  • 1.6 Market Analysis by End-user
    • 1.6.1 Overview: Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by End-user: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Ophthalmology Clinic
  • 1.7 Global Ophthalmic Perfluoropropane Gas (C3F8) Market Size & Forecast
    • 1.7.1 Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity (2021-2032)
    • 1.7.3 Global Ophthalmic Perfluoropropane Gas (C3F8) Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Alcon
    • 2.1.1 Alcon Details
    • 2.1.2 Alcon Major Business
    • 2.1.3 Alcon Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.1.4 Alcon Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Alcon Recent Developments/Updates
  • 2.2 Alchimia
    • 2.2.1 Alchimia Details
    • 2.2.2 Alchimia Major Business
    • 2.2.3 Alchimia Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.2.4 Alchimia Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Alchimia Recent Developments/Updates
  • 2.3 Scott Medical
    • 2.3.1 Scott Medical Details
    • 2.3.2 Scott Medical Major Business
    • 2.3.3 Scott Medical Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.3.4 Scott Medical Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Scott Medical Recent Developments/Updates
  • 2.4 DORC (ZEISS)
    • 2.4.1 DORC (ZEISS) Details
    • 2.4.2 DORC (ZEISS) Major Business
    • 2.4.3 DORC (ZEISS) Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.4.4 DORC (ZEISS) Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 DORC (ZEISS) Recent Developments/Updates
  • 2.5 Pharmpur
    • 2.5.1 Pharmpur Details
    • 2.5.2 Pharmpur Major Business
    • 2.5.3 Pharmpur Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.5.4 Pharmpur Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pharmpur Recent Developments/Updates
  • 2.6 BVI Medical
    • 2.6.1 BVI Medical Details
    • 2.6.2 BVI Medical Major Business
    • 2.6.3 BVI Medical Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.6.4 BVI Medical Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BVI Medical Recent Developments/Updates
  • 2.7 Fluoron GmbH
    • 2.7.1 Fluoron GmbH Details
    • 2.7.2 Fluoron GmbH Major Business
    • 2.7.3 Fluoron GmbH Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.7.4 Fluoron GmbH Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Fluoron GmbH Recent Developments/Updates
  • 2.8 Micromed
    • 2.8.1 Micromed Details
    • 2.8.2 Micromed Major Business
    • 2.8.3 Micromed Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.8.4 Micromed Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Micromed Recent Developments/Updates
  • 2.9 Shanghai Jesvis Medical Technology
    • 2.9.1 Shanghai Jesvis Medical Technology Details
    • 2.9.2 Shanghai Jesvis Medical Technology Major Business
    • 2.9.3 Shanghai Jesvis Medical Technology Ophthalmic Perfluoropropane Gas (C3F8) Product and Services
    • 2.9.4 Shanghai Jesvis Medical Technology Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Shanghai Jesvis Medical Technology Recent Developments/Updates

3 Competitive Environment: Ophthalmic Perfluoropropane Gas (C3F8) by Manufacturer

  • 3.1 Global Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ophthalmic Perfluoropropane Gas (C3F8) Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ophthalmic Perfluoropropane Gas (C3F8) Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ophthalmic Perfluoropropane Gas (C3F8) by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ophthalmic Perfluoropropane Gas (C3F8) Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ophthalmic Perfluoropropane Gas (C3F8) Manufacturer Market Share in 2025
  • 3.5 Ophthalmic Perfluoropropane Gas (C3F8) Market: Overall Company Footprint Analysis
    • 3.5.1 Ophthalmic Perfluoropropane Gas (C3F8) Market: Region Footprint
    • 3.5.2 Ophthalmic Perfluoropropane Gas (C3F8) Market: Company Product Type Footprint
    • 3.5.3 Ophthalmic Perfluoropropane Gas (C3F8) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ophthalmic Perfluoropropane Gas (C3F8) Market Size by Region
    • 4.1.1 Global Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ophthalmic Perfluoropropane Gas (C3F8) Average Price by Region (2021-2032)
  • 4.2 North America Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value (2021-2032)
  • 4.3 Europe Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value (2021-2032)
  • 4.5 South America Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Type (2021-2032)
  • 5.2 Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Type (2021-2032)
  • 5.3 Global Ophthalmic Perfluoropropane Gas (C3F8) Average Price by Type (2021-2032)

6 Market Segment by End-user

  • 6.1 Global Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by End-user (2021-2032)
  • 6.2 Global Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by End-user (2021-2032)
  • 6.3 Global Ophthalmic Perfluoropropane Gas (C3F8) Average Price by End-user (2021-2032)

7 North America

  • 7.1 North America Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Type (2021-2032)
  • 7.2 North America Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by End-user (2021-2032)
  • 7.3 North America Ophthalmic Perfluoropropane Gas (C3F8) Market Size by Country
    • 7.3.1 North America Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by End-user (2021-2032)
  • 8.3 Europe Ophthalmic Perfluoropropane Gas (C3F8) Market Size by Country
    • 8.3.1 Europe Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by End-user (2021-2032)
  • 9.3 Asia-Pacific Ophthalmic Perfluoropropane Gas (C3F8) Market Size by Region
    • 9.3.1 Asia-Pacific Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Type (2021-2032)
  • 10.2 South America Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by End-user (2021-2032)
  • 10.3 South America Ophthalmic Perfluoropropane Gas (C3F8) Market Size by Country
    • 10.3.1 South America Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by End-user (2021-2032)
  • 11.3 Middle East & Africa Ophthalmic Perfluoropropane Gas (C3F8) Market Size by Country
    • 11.3.1 Middle East & Africa Ophthalmic Perfluoropropane Gas (C3F8) Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ophthalmic Perfluoropropane Gas (C3F8) Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ophthalmic Perfluoropropane Gas (C3F8) Market Drivers
  • 12.2 Ophthalmic Perfluoropropane Gas (C3F8) Market Restraints
  • 12.3 Ophthalmic Perfluoropropane Gas (C3F8) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ophthalmic Perfluoropropane Gas (C3F8) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ophthalmic Perfluoropropane Gas (C3F8)
  • 13.3 Ophthalmic Perfluoropropane Gas (C3F8) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ophthalmic Perfluoropropane Gas (C3F8) Typical Distributors
  • 14.3 Ophthalmic Perfluoropropane Gas (C3F8) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ophthalmic Perfluoropropane Gas (C3F8) market size was valued at US$ 81.29 million in 2025 and is forecast to a readjusted size of US$ 115 million by 2032 with a CAGR of 5.1% during review period.
    In 2025, global Ophthalmic Perfluoropropane Gas (C3F8) production reached approximately 160 k units, with an average global market price of around US$495 per unit. Ophthalmic perfluoropropane gas (C3F8) is a colorless, odorless, non-toxic inert gas, chemically stable, insoluble in water, belongs to Class III medical devices, product specifications are usually 15ml. It is mainly used in vitreo-retinal detachment surgery, as a filling gas material in the eye, by absorbing nitrogen and oxygen in the surrounding tissue and expanding, creating a supporting effect on the retina, promoting its reduction and healing. The gas plays an important role in eye surgery, which can improve the surgical cure rate, reduce surgical risks and complications, simplify the surgical process, and reduce the workload of doctors.
    Ophthalmic perfluoropropane gas is an essential intraocular tamponade material in vitreoretinal surgery, with market demand directly linked to the global burden of ophthalmic diseases. Globally, population aging, rising myopia prevalence, and the spread of chronic eye diseases such as diabetic retinopathy collectively drive stable clinical demand for long-acting intraocular filling gases. The widespread adoption of minimally invasive vitrectomy has further increased the clinical usage frequency of this product, and the standardization of surgical techniques has promoted its penetration in medical institutions at different levels.
    The production of this product has high technical barriers, with strict requirements for gas purity, impurity control, and sterile processing. Major global markets classify it as a high-risk medical device and implement strict supervision. Long product registration cycles and high clinical verification requirements constitute significant market entry barriers. Meanwhile, the production of fluorine-containing gases is constrained by global environmental protection policies, and raw material supply and capacity layout need to comply with national greenhouse gas emission control requirements, which pose higher challenges to supply chain stability and flexibility.
    This report is a detailed and comprehensive analysis for global Ophthalmic Perfluoropropane Gas (C3F8) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End-user. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ophthalmic Perfluoropropane Gas (C3F8) market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Ophthalmic Perfluoropropane Gas (C3F8) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Ophthalmic Perfluoropropane Gas (C3F8) market size and forecasts, by Type and by End-user, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Ophthalmic Perfluoropropane Gas (C3F8) market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ophthalmic Perfluoropropane Gas (C3F8)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ophthalmic Perfluoropropane Gas (C3F8) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, Alchimia, Scott Medical, DORC (ZEISS), Pharmpur, BVI Medical, Fluoron GmbH, Micromed, Shanghai Jesvis Medical Technology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ophthalmic Perfluoropropane Gas (C3F8) market is split by Type and by End-user. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End-user in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pure C3F8
    Gas Mixture
    Market segment by Specification
    30 ml/unit
    40 ml/unit
    Others
    Market segment by Application
    Retinal Detachment Repair
    Macular Hole Surgery
    Others
    Market segment by End-user
    Hospital
    Ophthalmology Clinic
    Major players covered
    Alcon
    Alchimia
    Scott Medical
    DORC (ZEISS)
    Pharmpur
    BVI Medical
    Fluoron GmbH
    Micromed
    Shanghai Jesvis Medical Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ophthalmic Perfluoropropane Gas (C3F8) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ophthalmic Perfluoropropane Gas (C3F8), with price, sales quantity, revenue, and global market share of Ophthalmic Perfluoropropane Gas (C3F8) from 2021 to 2026.
    Chapter 3, the Ophthalmic Perfluoropropane Gas (C3F8) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ophthalmic Perfluoropropane Gas (C3F8) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by End-user, with sales market share and growth rate by Type, by End-user, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ophthalmic Perfluoropropane Gas (C3F8) market forecast, by regions, by Type, and by End-user, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Perfluoropropane Gas (C3F8).
    Chapter 14 and 15, to describe Ophthalmic Perfluoropropane Gas (C3F8) sales channel, distributors, customers, research findings and conclusion.

    Buy now